This approach displayed a diagnostic accuracy to discriminate ALS from PD (or controls) with 89% (89%) sensitivity and 77% (83%) specificity, with the caveat that this study lacked direct evidence of antibody-bound TDP-43 by immunoblotting. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.